🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
This phase II randomized trial compares the efficacy and safety of Toripali...
Status
Recruiting
Location
Dongguan People's Hospital
Start Date
2026-03-12
Trial ID
NCT07362979
Test the safety, immune response and efficacy of GVAX pancreas vaccine (wit...
Status
Completed
Location
Scottsdale Healthcare Research Institute
Start Date
2014-02-05
Trial ID
NCT02004262
Treatments Being Tested
The prognosis of pancreatic cancer is extremely poor. Current guidelines re...
Status
Unknown
Location
The second affiliated hospital of Zhejiang University
Start Date
2018-07-01
Trial ID
NCT03633734
Treatments Being Tested
This is a multicenter, open-label, prospective, single-arm, phase II study ...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2025-10-25
Trial ID
NCT07296705
Treatments Being Tested
This is a single arm phase II study assessing the activity of atezolizumab ...
Status
Terminated
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2018-12-19
Trial ID
NCT03737123
Treatments Being Tested
Durvalumab and Tremelimumab in combination with first-line chemotherapy in ...
Status
Completed
Location
Research Site
Start Date
2016-04-28
Trial ID
NCT02658214
Treatments Being Tested
This study is a multi-cohort, open-label, multi-center exploratory clinical...
Status
Not Yet Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2024-10-10
Trial ID
NCT06649448
This is an open label, randomized, Phase II multicenter study designed to e...
Status
Withdrawn
Location
Asklepios Fachkliniken München-Gauting
Start Date
2022-05-20
Trial ID
NCT05383001
Treatments Being Tested